Pharmacogenetics of Opioid Use Disorder Treatment Richard C. CristToni-Kim ClarkeWade H. Berrettini Leading Article 05 April 2018 Pages: 305 - 320
Risk of Intracranial Hemorrhage Associated with the Use of Antidepressants Inhibiting Serotonin Reuptake: A Systematic Review Antonios DourosMatthew AdesChristel Renoux Systematic Review 13 March 2018 Pages: 321 - 334
Treatment Strategies for Dravet Syndrome Kelly G. KnuppElaine C. Wirrell Review Article 28 March 2018 Pages: 335 - 350
The Safety of Second-Generation Antipsychotics During Pregnancy: A Clinically Focused Review Per DamkierPoul Videbech Review Article 10 April 2018 Pages: 351 - 366
Effect of Statin Intensity on the Risk of Epilepsy After Ischaemic Stroke: Real-World Evidence from Population-Based Health Claims Fang-Ju LinHung-Wei LinYunn-Fang Ho Original Research Article 04 April 2018 Pages: 367 - 376
Perinatal Outcomes of Women Diagnosed with Attention-Deficit/Hyperactivity Disorder: An Australian Population-Based Cohort Study Alison S. PoultonBruce ArmstrongRalph K. Nanan Original Research Article 19 March 2018 Pages: 377 - 386
Pooled Analyses of Phase III Studies of ADS-5102 (Amantadine) Extended-Release Capsules for Dyskinesia in Parkinson’s Disease Lawrence W. ElmerJorge L. JuncosRajiv Patni Original Research Article Open access 12 March 2018 Pages: 387 - 398
Author Correction to: Pooled Analyses of Phase III Studies of ADS-5102 (Amantadine) Extended-Release Capsules for Dyskinesia in Parkinson’s Disease Lawrence W. ElmerJorge L. JuncosRajiv Patni Author Correction 10 April 2018 Pages: 399 - 400